Related Experiment Video
Updated: Aug 6, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
HIF-1α-induced upregulated miR-322 forms a feedback loop by targeting Smurf2 and Smad7 to activate
Wei Dong1, Chen Dong1, Jianbing Zhu1
1Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Abstract:
Myocardial ischemia/reperfusion injury (MIRI) is a major cause of heart failure after myocardial infarction. It has been reported that miR-322 is involved in MIRI progression, while the molecular mechanism of miR-322 in regulating MIRI progression needs to be further probed. MIRI cell model was established by oxygen-glucose deprivation/reoxygenation (OGD/R). Cell viability was assessed using MTS assay. Flow cytometry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining were employed to analyze cell apoptosis. In addition, the interactions between miR-322, Smad7/Smurf2, hypoxia-inducible factor alpha (HIF-1α), and β-catenin were verified by dual-luciferase reporter gene assay. Our results displayed that miR-322 was significantly downregulated in OGD/R-treated H9c2 cells, and its overexpression resulted in increased cell viability and reduced the apoptosis. Smurf2 and Smad7 were identified as the direct targets of miR-322. Smad7 knockdown or Smurf2 knockdown increased OGD/R-treated H9c2 cell viability and suppressed the apoptosis. Meanwhile, miR-322 mimics abolished the mitigating effect of Smad7 or Smurf2 overexpression on MIRI. In addition, the Smad3/β-catenin pathway was identified as the downstream pathway of Smurf2/Smad7. Moreover, it was found that HIF-1α interacted with the miR-322 promoter, and β-catenin interacted with the HIF-1α promoter to form a loop. HIF-1α-induced upregulated miR-322 activated the Smad3/β-catenin pathway by targeting Smurf2 and Smad7 to improve MIRI; meanwhile, β-catenin/HIF-1α formed a positive feedback loop to continuously improve MIRI.
Insights
MicroRNA-322 (miR-322) protects against myocardial ischemia/reperfusion injury (MIRI) by upregulating the Smad3/β-catenin pathway. This involves a feedback loop between beta-catenin and hypoxia-inducible factor alpha (HIF-1α).
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Cellular Signaling
Background:
- Myocardial ischemia/reperfusion injury (MIRI) is a significant contributor to heart failure post-myocardial infarction.
- The precise molecular mechanisms underlying miR-322's role in MIRI progression require further elucidation.
Purpose of the Study:
- To investigate the role and molecular mechanism of microRNA-322 (miR-322) in regulating myocardial ischemia/reperfusion injury (MIRI).
- To identify the key molecular targets and signaling pathways modulated by miR-322 during MIRI.
Main Methods:
- Establishment of an MIRI cell model using oxygen-glucose deprivation/reoxygenation (OGD/R) in H9c2 cells.
- Assessment of cell viability (MTS assay) and apoptosis (flow cytometry, TUNEL staining).
- Verification of molecular interactions using dual-luciferase reporter gene assays.
Main Results:
- miR-322 was significantly downregulated in OGD/R-treated cells; its overexpression enhanced cell viability and reduced apoptosis.
- Smurf2 and Smad7 were identified as direct targets of miR-322, and their knockdown mimicked the protective effects of miR-322.
- A positive feedback loop involving HIF-1α and β-catenin was identified, regulating miR-322 expression and activating the Smad3/β-catenin pathway.
Conclusions:
- miR-322 plays a protective role in MIRI by targeting Smurf2 and Smad7, thereby activating the Smad3/β-catenin pathway.
- The β-catenin/HIF-1α positive feedback loop contributes to the protective effects of miR-322 in MIRI, offering potential therapeutic targets.

